Broadcom lands big deal for its specialty chips. Wall Street sees the stock rising as much as 80%

Broadcom struck deals to supply multiple gigawatts of next-generation TPUs to Anthropic and to produce future AI hardware for Google through 2031; shares jumped ~3% on the news and are up ~112% year-to-date. Analysts are overwhelmingly positive (49 of 51 buy/strong buy) with price targets of roughly $430–$575 (implying ~37%–83% upside); JPMorgan and Citi now see FY2027 AI revenue potential well above prior $100B targets (JPMorgan cites >$120B+, Citi sees up to ~$130B).

Analysis

Broadcom's deal visibility materially shifts investor focus from demand uncertainty to execution risk: long-term supply commitments convert capex timing into revenue cadence, which supports a higher multiple but makes the stock increasingly binary around ramp milestones. The immediate second-order winners are specialized supply-chain nodes (advanced packaging, HBM suppliers, test/assembly partners) that sit between chip design and datacenter deployment — constrained capacity there can create outsized margin tailwinds for whoever controls supply.

Key risks center on delivery rather than demand. A high-volume ramp exposes Broadcom to yield and component bottlenecks (HBM, substrates, OSAT capacity) that could dent gross margins by hundreds of basis points if not navigated cleanly; these are 6–24 month execution risks. Strategically, customer concentration raises renegotiation and pricing risk: a small set of hyperscalers or labs can exert leverage if alternative GPU/accelerator architectures close performance/cost gaps over the same multi-year horizon.

Catalyst cadence to monitor: quarterly shipments/volume metrics, HBM substrate lead times, OSAT utilization, and any customer disclosure of alternate sourcing — these will move the story from qualitative TA to quantifiable revenue. Near-term price action will be driven by analyst updates and flows; medium-term valuation depends on realized ASPs, mix, and margin retention across the next 12–36 months.

Consensus currently prizes blue-sky revenue growth; the contrarian read is that much of that upside is already priced and conditional on flawless execution — which historically is a low-probability event at these scales. That makes asymmetric trades (capped upside/low-cost hedge) more attractive than outright leverage into the rally.

Key Decisions for Investors

• Long AVGO equity (core position 2–4% portfolio) with a protective collar: buy AVGO and simultaneously sell 3–6 month covered calls and buy 12–18 month puts to cap downside. Rationale: capture re-rating while limiting a single-event execution miss; target 30–50% upside vs defined downside (~10–15% after hedges).
• Buy AVGO Jan-2027 LEAPS (bull-call spread to finance cost): long 2027 LEAP calls and sell higher strike 2027 calls to reduce premium. Timeframe 12–24 months, objective 50–100% return if ramp sustains; max loss = net premium ~5% of notional exposure.
• Small pair trade: go long AVGO / short GOOGL in 1:0.5 notional (size ~1–2% net exposure) for 3–12 months. Rationale: hedge macro/cloud cyclicality and monetize re-rating disparity if Broadcom execution outpaces Google’s margin-bearing capex; risk: if cloud demand compels higher Google profitability, pair will underperform—keep size small and monitor rolling rebalancing.
• Event hedge: buy inexpensive 3–6 month AVGO put spreads (OTM) sized to offset a 20–30% drawdown risk around next two earnings cycles. Use these as crash protection rather than outright insurance to limit carry cost.
• Monitor supplier and OSAT equities (tradeable proxies) for leading indicators — if those names print extended lead-times/price increases, add to AVGO exposure; conversely, signs of easing substrate/HBM lead-times should be used to tighten stop-losses on hedged short positions.